During the corresponding time, Prestige Consumer Healthcare Inc recorded a revenue increase by 6.57 % year on year, sequentially revenue fell by -5.88 %. While revenue at the Prestige Consumer Healthcare Inc 's corporate clients
Prestige Consumer Healthcare Inc's Comment on Sales, Marketing and Customers
The company operates through two primary segments: North American OTC Healthcare and International OTC Healthcare, with the majority of net revenues generated from the North American segment. Its major brands cover various market categories, including analgesics, dermatologicals, cough and cold, eye and ear care, oral care, and gastrointestinal products. Key brands and their market positions include BC and Goody's (ranked #1 in Analgesic Powders), Boudreaux's Butt Paste (#4 in Baby Ointments), Chloraseptic (#1 in Sore Throat Liquids and Lozenges), Clear Eyes (#3 in Redness Relief), Compound W (#1 in Wart Removal), Debrox (#1 in Ear Wax Removal), DenTek (#4 in Oral Care), Dramamine (#1 in Motion Sickness Relief), Fleet (#1 in Adult Enemas and Suppositories), Gaviscon (#1 in Upset Stomach Remedies), and Luden's (#4 in Non-Medicated Cough Drops). These brands have widespread consumer recognition and retail distribution across major channels, accounting for approximately 83% of the company's total revenues in recent years.
News about Prestige Consumer Healthcare Inc Contracts
Introduction Insight Pharmaceuticals, a subsidiary of Prestige Consumer Healthcare Inc., has issued a voluntary recall of two lots of TING 2% Miconazole Nitrate Athletes Foot Spray Antifungal Spray Powder, due to the presence of elevated levels of benzene. Although benzene is not an ingredient in any Ting Antifungal Spray products, the review revealed that unexpected levels of benzene were found in the propellant used in the affected lots. This article discusses the details of the recall, its potential impact on consumers, and the action taken by the company to address the issue. Recall Details The recall has been initiated following a recent review conducted by Insight Pharmaceuticals and t...
Prestige Consumer Healthcare Inc’s Comment on Sales, Marketing and Customers
The company operates through two primary segments: North American OTC Healthcare and International OTC Healthcare, with the majority of net revenues generated from the North American segment. Its major brands cover various market categories, including analgesics, dermatologicals, cough and cold, eye and ear care, oral care, and gastrointestinal products. Key brands and their market positions include BC and Goody's (ranked #1 in Analgesic Powders), Boudreaux's Butt Paste (#4 in Baby Ointments), Chloraseptic (#1 in Sore Throat Liquids and Lozenges), Clear Eyes (#3 in Redness Relief), Compound W (#1 in Wart Removal), Debrox (#1 in Ear Wax Removal), DenTek (#4 in Oral Care), Dramamine (#1 in Motion Sickness Relief), Fleet (#1 in Adult Enemas and Suppositories), Gaviscon (#1 in Upset Stomach Remedies), and Luden's (#4 in Non-Medicated Cough Drops). These brands have widespread consumer recognition and retail distribution across major channels, accounting for approximately 83% of the company's total revenues in recent years.
Sources:
Prestige Consumer Healthcare Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Prestige Consumer Healthcare Inc’s corporate clients.
For your research, we’ve provided 9 tables on Prestige Consumer Healthcare Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
97.98 %